Agenus Secures Up to $340 Million in Private Financing to Advance Phase 3 ROBBIN Trial for MSS Colon Cancer Agenus Inc., a biotechnology company focused on developing innovative immuno-oncology therapies, has announced that it has entered into a securities purchase…
AdvanCell Raises US$315 Million in Oversubscribed Series D Financing to Advance Lead-212 Targeted Alpha Therapy Platform AdvanCell, a clinical-stage radiopharmaceutical company focused on developing targeted alpha therapies for cancer, has announced the successful completion of an oversubscribed and expanded US$315…
Anodyne Nanotech Raises $12.6 Million Series A to Advance Weekly GLP-1 Patch for Obesity and Expand Transdermal Drug Delivery Platform Anodyne Nanotech Inc., a clinical-stage biotechnology company focused on transforming chronic disease treatment through transdermal drug delivery, has announced the…
Biocom Report Highlights California Life Science Industry’s $394 Billion Economic Impact and Resilience in 2025 Biocom, the largest life science membership association representing companies across California and other major life science markets, has released its 2026 Life Science Economic Impact…
BioTalent Canada Launches BioInsights to Deliver Labour Market Intelligence for Canada’s Bio-Economy BioTalent Canada has unveiled BioInsights, a new labour market intelligence consulting service designed to support organizations operating across Canada’s growing bio-economy. The new offering is intended to provide…
WISE Raises €30 Million in Oversubscribed Series D Round to Advance Heron Spinal Cord Stimulation Lead and Expand Neurotechnology Platform WISE S.p.A., an Italian medical device company developing advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interface applications, has completed…
bioAffinity Technologies Closes $3.2 Million Public Offering to Support Growth in Lung Disease Diagnostics bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic tools for the early detection of lung cancer and other pulmonary diseases, has completed a…
Simulations Plus Agrees to $375 Million Acquisition by Altaris, Signaling New Chapter in AI-Driven Drug Development Simulations Plus, Inc., a recognized leader in model-informed drug development and artificial intelligence-enabled pharmaceutical research solutions, has entered into a definitive agreement to be…
Cellares Secures Additional $50 Million Investment, Expanding Series D Financing to $327 Million to Accelerate Global Cell Therapy Manufacturing Network Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO) dedicated to advancing automated cell therapy production, has announced a…
ARK Invest Led by Cathie Wood Joins Cellares’ $277 Million Series D Funding Round Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO), has announced a new strategic investment from ARK Invest as part of its Series D financing…
Rallybio and Avenzo Therapeutics Announce Merger Backed by $215 Million Financing to Advance Next-Generation Oncology Pipeline Rallybio Corporation and Avenzo Therapeutics have entered into a definitive merger agreement that will create a publicly traded oncology-focused biotechnology company with a portfolio…
Teleflex Launches $500 Million Senior Notes Offering to Support Debt Refinancing Strategy Teleflex Incorporated has announced the launch of a private offering of $500 million in aggregate principal amount of senior notes due in 2032, marking an important step in…